country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

20 Results for "

SREBP2

" in MedChemExpress (MCE) Product Catalog:

Products (20)

Sort by :

Categories

By Targets

Hosts:

Reactivities:

Applications:

Isotypes:

Conjugations:

Clonalities:

Modifications:

Products

Fatostatin

60 Publications Verification

Cat. No.: HY-14452

CAS No.: 125256-00-0

Purity: 99.85%

Synonyms: 125B11

Target:

Fatty Acid Synthase (FASN)

Research Areas:

Cancer

Fatostatin (125B11), a specific inhibitor of SREBP activation, impairs the activation of SREBP-1 and SREBP-2. Fatostatin binds to SCAP (SREBP cleavage-activating protein), and inhibits the ER-Golgi translocation of SREBPs. Fatostatin decreases the transcription of lipogenic genes in cells. Fatostatin possesses antitumor properties, and lowers hyperglycemia in ob/ob mice ^[2].

Compare

Please select quantity

August 31

Get Quote

View All Sizes

Fatostatin hydrobromide

60 Publications Verification

Cat. No.: HY-14452A

CAS No.: 298197-04-3

Purity: 99.52%

Synonyms: 125B11 hydrobromide

Target:

Fatty Acid Synthase (FASN)

Research Areas:

Cancer

Fatostatin hydrobromide (125B11 hydrobromide), a specific inhibitor of SREBP activation, impairs the activation of SREBP-1 and SREBP-2. Fatostatin hydrobromide binds to SCAP (SREBP cleavage-activating protein), and inhibits the ER-Golgi translocation of SREBPs. Fatostatin hydrobromide decreases the transcription of lipogenic genes in cells. Fatostatin hydrobromide possesses antitumor properties, and lowers hyperglycemia in ob/ob mice ^[2].

Compare

Please select quantity

August 31

Get Quote

View All Sizes

Taurolithocholic acid

6 Cited Publications

Cat. No.: HY-113308

CAS No.: 516-90-5

Purity: 98.06%

Target:

Calcium Channel Ferroptosis PI3K Akt HBV Reactive Oxygen Species (ROS)

Research Areas:

Cardiovascular Disease Infection Inflammation/Immunology

Taurolithocholic acid is an orally active bile acid and antiviral agent. Taurolithocholic acid upregulates FADS2 by activating the TGR5-PI3K/AKT-SREBP2 signaling axis, inhibits SFTSV-induced ferroptosis (Ferroptosis), viral replication and viral entry of HBV/HDV, while reducing the release of IL-1β, lipid ROS and LDH. While exerting antiviral protective effects, Taurolithocholic acid also stimulates the recycling of hepatocellular membrane transporters, impairs canalicular bile acid secretion function, and induces hepatocyte cholestasis, apoptosis and acute hepatocellular injury. Taurolithocholic acid serves as an experimental model compound for hepatocellular cholestasis. At concentrations ≤200 μM, Taurolithocholic acid shows no cytotoxicity and does not activate the interferon pathway. Taurolithocholic acid not only protects mice from lethal SFTSV infection but also is suitable for studies related to severe fever with thrombocytopenia syndrome and cholestasis ^[2] .

Compare

Please select quantity

August 31

Get Quote

View All Sizes

Taurolithocholic acid sodium salt

6 Cited Publications

Cat. No.: HY-113308A

CAS No.: 6042-32-6

Purity: 99.81%

Category:

Animals Metabolic Disease Disease Research Fields Steroids

Target:

Calcium Channel Ferroptosis PI3K Reactive Oxygen Species (ROS) Akt HBV

Taurolithocholic acid sodium salt is an orally active bile acid and antiviral agent. Taurolithocholic acid sodium salt upregulates FADS2 by activating the TGR5-PI3K/AKT-SREBP2 signaling axis, inhibits SFTSV-induced ferroptosis, viral replication and viral entry of HBV/HDV, while reducing the release of IL-1β, lipid ROS and LDH. While exerting antiviral protective effects, Taurolithocholic acid sodium salt also stimulates the recycling of hepatocellular membrane transporters, impairs canalicular bile acid secretion function, and induces hepatocyte cholestasis, apoptosis and acute hepatocellular injury. Taurolithocholic acid sodium salt serves as an experimental model compound for hepatocellular cholestasis. At concentrations ≤200 μM, Taurolithocholic acid sodium salt shows no cytotoxicity and does not activate the interferon pathway. Taurolithocholic acid sodium salt not only protects mice from lethal SFTSV infection but also is suitable for studies related to severe fever with thrombocytopenia syndrome and cholestasis ^[2] .

Compare